Literature DB >> 23270628

The assessment of cryopreservation conditions for human umbilical cord stroma-derived mesenchymal stem cells towards a potential use for stem cell banking.

Deniz Balci1, Alp Can.   

Abstract

Human umbilical cord stroma-derived mesenchymal stem cells (hUCS-MSCs) are considered as a remarkable and promising stem cell source to be potentially used in cellular therapies. While no graft rejection has been reported in the recipient organism even in xeno-transplantation studies, attenuate tumor cell growth and gene transfers have been experimentally shown. In this study, we have demonstrated a reliable, reproducible and efficient cryopreservation method of hUCS-MSCs resulting in one of the highest cell survival rates reported so far. Conventional, computer-controlled multistep slow freezing (MSSF), and vitrification methods were comparatively tested using cell permeable [dimethylsulfoxide (DMSO), ethylene glycol] and impermeable [trehalose, sucrose, hydroxyethyl starch (HES), human serum albumin] cryoprotectant agents (CPAs). After determining the ice nucleation point for each solution, latent heat evolution was suppressed during freezing, followed by a cooling process to -40°C at 1°C/min or 0.3°C/min. The efficiency of the cryopreservation techniques used was determined by cell viability and proliferation assays, the expression of cell surface markers, cytoskeletal proteins and chromosome alignments. The cell survival rate was found to be highest (87 ± 5%) by MSSF with sucrose (0.1 M) +DMSO (10%) at 1°C/min freezing rate. In this group, no significant difference was noted before and after the cryopreservation in cell morphology, cytokeratin, vimentin, and α-smooth muscle actin profiles and the expressions of CD105, CD90, CD73, CD29 and HLA-DR. Second highest cell survival ratio (85 ± 6%) was obtained in DMSO (10%) alone at 1°C/min freezing rate. Interestingly, poor (18 ± 15%) cell survival rates were obtained after vitrification. Cumulatively, results indicated that MSSF favors the other freezing protocols with an addition of sucrose or DMSO alone depending on the freezing rate used.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23270628     DOI: 10.2174/1574888x11308010008

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  8 in total

1.  Expansion of Human Dental Pulp Cells In Vitro Under Different Cryopreservation Conditions.

Authors:  Ming Yan; Ola A Nada; Lan Kluwe; Martin Gosau; Ralf Smeets; Reinhard E Friedrich
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

2.  Human umbilical cord mesenchymal stromal cells in regenerative medicine.

Authors:  Michael S Detamore
Journal:  Stem Cell Res Ther       Date:  2013-11-25       Impact factor: 6.832

3.  Vitrification of Rhesus Macaque Mesenchymal Stem Cells and the Effects on Global Gene Expression.

Authors:  Xufeng Fu; Yaping Yan; Shanshan Li; Junfeng Wang; Bin Jiang; Hong Wang; Yanchao Duan; Tao Tan; Fei Gao; Desheng Gong; Yuyu Niu; Weizhi Ji; Bingrong Zheng; Wei Si
Journal:  Stem Cells Int       Date:  2017-10-24       Impact factor: 5.443

4.  Comparative Bioactivity Analysis for Off-the-Shelf and Culture-Rescued Umbilical Cord-Derived Mesenchymal Stem/Stromal Cells in a Xeno- and Serum-Free Culture System.

Authors:  Minh Quang Nguyen; Hue T H Bui; Anh Nguyen Thi Tuyet; Trinh Thi Hong Nhung; Duc M Hoang; Nguyen Thanh Liem; Van T Hoang
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

5.  Effects of Cryopreservation on Canine Multipotent Stromal Cells from Subcutaneous and Infrapatellar Adipose Tissue.

Authors:  Wei Duan; Mandi J Lopez
Journal:  Stem Cell Rev Rep       Date:  2016-04       Impact factor: 5.739

6.  Cryopreservation of Human Wharton's Jelly-derived Mesenchymal Stem Cells Following Controlled Rate Freezing Protocol Using Different Cryoprotectants; A Comparative Study.

Authors:  Sharath Belame Shivakumar; Dinesh Bharti; Si-Jung Jang; Sun-Chul Hwang; Ji-Kwon Park; Jeong-Kyu Shin; June-Ho Byun; Bong-Wook Park; Gyu-Jin Rho
Journal:  Int J Stem Cells       Date:  2015-11       Impact factor: 2.500

Review 7.  Principal Criteria for Evaluating the Quality, Safety and Efficacy of hMSC-Based Products in Clinical Practice: Current Approaches and Challenges.

Authors:  Juan Antonio Guadix; Javier López-Beas; Beatriz Clares; José Luis Soriano-Ruiz; José Luis Zugaza; Patricia Gálvez-Martín
Journal:  Pharmaceutics       Date:  2019-10-24       Impact factor: 6.321

Review 8.  Therapeutic Potential of Wharton's Jelly Mesenchymal Stem Cells for Diabetes: Achievements and Challenges.

Authors:  Mohamed M Kamal; Dina H Kassem
Journal:  Front Cell Dev Biol       Date:  2020-01-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.